Merck Reportedly Goes To Bat In Takeover Battle. But Genomics Stock Reverses.

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 6 hours ago

Oct. 9 has loomed large in stock-market history. Why investors still shouldn’t buy into an October jinx.

Not just one, but two, major market turning points since 2000 have occurred on that day.

MarketWatch

marketsabout 6 hours ago

Marvell just impressed Wall Street with ‘good numbers plus a better story’

Marvell’s stock is popping after the company not only delivered with its financial forecasts but also demonstrated its diversified mix of customers and products.

MarketWatch

marketsabout 6 hours ago

The S&P 500 is back in record territory as the ‘Magnificent Seven’ ride to the rescue

After trading sideways for much of the past year, the “Magnificent Seven” have been staging a comeback, helping to re-energize a bull market threatened by rising bond yields and stubbornly high crude-oil prices.

MarketWatch